57
Views
5
CrossRef citations to date
0
Altmetric
Expert Opinion

Agomelatine and its therapeutic potential in the depressed patient

&
Pages 423-428 | Published online: 25 Nov 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Susana Barbosa-Méndez, Gilberto Perez-Sánchez & Alberto Salazar-Juárez. (2023) Agomelatine decreases cocaine-induced locomotor sensitisation and dopamine release in rats. The World Journal of Biological Psychiatry 24:5, pages 400-413.
Read now
Anselm Wong, Carl Lee & Julia Lee. (2018) Agomelatine overdose and related toxicity. Toxicology Communications 2:1, pages 62-65.
Read now
Jan Pecenak. (2013) Agomelatine as monotherapy for major depression: an outpatient, open-label study. Neuropsychiatric Disease and Treatment 9, pages 1595-1604.
Read now
Nava Zisapel. (2012) Drugs for insomnia. Expert Opinion on Emerging Drugs 17:3, pages 299-317.
Read now
Roger M Pinder. (2007) New antidepressants or more of the same?. Neuropsychiatric Disease and Treatment 3:5, pages 519-520.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.